Working… Menu

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (PANIHL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02779192
Recruitment Status : Unknown
Verified August 2018 by Sound Pharmaceuticals, Incorporated.
Recruitment status was:  Not yet recruiting
First Posted : May 20, 2016
Last Update Posted : August 24, 2018
Information provided by (Responsible Party):
Sound Pharmaceuticals, Incorporated

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : October 2021